Bank of Montreal
OPNT

Bank of Montreal’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Bank of Montreal’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,025
Closed -$21K – 5286
2021
Q1 		$21K Hold
2,025
– – ﹤0.01% 4051
2020
Q4 		$18K Hold
2,025
– – ﹤0.01% 4471
2020
Q3 		$15K Buy
2,025
+1,800
+800% +$16K ﹤0.01% 3963
2020
Q2 		$2K Buy
+225
New +$2.33K ﹤0.01% 4536

Other funds holding OPNT

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of Montreal's OPNT Position: Q2 2021 in Review

Bank of Montreal sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q2 2021, closing a stake of 2,025 shares — an estimated $21K sold.

Bank of Montreal first reported a position in OPNT in Q2 2020 and held it in 4 quarters. The position peaked at $21K in Q1 2021. 26 funds tracked by Wall St. Rank hold OPNT as of Q2 2021.

  • Bank of Montreal reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 2,025 Opiant Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $21K.
  • Bank of Montreal first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Bank of Montreal's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $21K in Q1 2021.
  • 26 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.